250 related articles for article (PubMed ID: 21357545)
1. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.
Wigglesworth KM; Racki WJ; Mishra R; Szomolanyi-Tsuda E; Greiner DL; Galili U
J Immunol; 2011 Apr; 186(7):4422-32. PubMed ID: 21357545
[TBL] [Abstract][Full Text] [Related]
2. Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction.
Galili U; Wigglesworth K; Abdel-Motal UM
Burns; 2010 Mar; 36(2):239-51. PubMed ID: 19501971
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.
Galili U
J Immunol Res; 2015; 2015():589648. PubMed ID: 25922849
[TBL] [Abstract][Full Text] [Related]
4. Topical α-gal nanoparticles accelerate diabetic wound healing.
Kaymakcalan OE; Abadeer A; Goldufsky JW; Galili U; Karinja SJ; Dong X; Jin JL; Samadi A; Spector JA
Exp Dermatol; 2020 Apr; 29(4):404-413. PubMed ID: 32027409
[TBL] [Abstract][Full Text] [Related]
5. Accelerated porcine wound healing after treatment with α-gal nanoparticles.
Hurwitz ZM; Ignotz R; Lalikos JF; Galili U
Plast Reconstr Surg; 2012 Feb; 129(2):242e-251e. PubMed ID: 22286440
[TBL] [Abstract][Full Text] [Related]
6. α-Gal Nanoparticles in Wound and Burn Healing Acceleration.
Galili U
Adv Wound Care (New Rochelle); 2017 Mar; 6(3):81-92. PubMed ID: 28289553
[No Abstract] [Full Text] [Related]
7. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Galili U; Wigglesworth K; Abdel-Motal UM
J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027
[TBL] [Abstract][Full Text] [Related]
8. α-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment.
Galili U; Goldufsky JW; Schaer GL
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232789
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the natural anti-Gal antibody and its past and future relevance to medicine.
Galili U
Xenotransplantation; 2013; 20(3):138-47. PubMed ID: 23577774
[TBL] [Abstract][Full Text] [Related]
10. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
11. Antigen-Mediated, Macrophage-Stimulated, Accelerated Wound Healing Using α-Gal Nanoparticles.
Kaymakcalan OE; Karinja S; Abadeer A; Dong X; Jin JL; Galili U; Spector JA
Ann Plast Surg; 2018 Apr; 80(4 Suppl 4):S196-S203. PubMed ID: 29481481
[TBL] [Abstract][Full Text] [Related]
12. Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles.
Galili U
Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892895
[TBL] [Abstract][Full Text] [Related]
13. Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction.
Galili U
Clin Dev Immunol; 2011; 2011():134020. PubMed ID: 22162709
[TBL] [Abstract][Full Text] [Related]
14. Topical α-Gal Nanoparticles Enhance Wound Healing in Radiated Skin.
Samadi A; Buro J; Dong X; Weinstein A; Lara DO; Celie KB; Wright MA; Gadijko MA; Galili U; Spector JA
Skin Pharmacol Physiol; 2022; 35(1):31-40. PubMed ID: 34348342
[TBL] [Abstract][Full Text] [Related]
15. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
17. Avoiding detrimental human immune response against Mammalian extracellular matrix implants.
Galili U
Tissue Eng Part B Rev; 2015 Apr; 21(2):231-41. PubMed ID: 25315097
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.
Abdel-Motal UM; Wigglesworth K; Galili U
Cancer Immunol Immunother; 2009 Oct; 58(10):1545-56. PubMed ID: 19184002
[TBL] [Abstract][Full Text] [Related]
19. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
Galili U
Front Mol Biosci; 2021; 8():746883. PubMed ID: 34805272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
